cas 401647-22-1|| where to buy N-methyl-1-(3-methylisoxazol-5-yl)methanamine

Nom du produit:N-methyl-1-(3-methylisoxazol-5-yl)methanamine

IUPAC Name:methyl[(3-methyl-1,2-oxazol-5-yl)methyl]amine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM125217-1g	in stock	ƥƿƿ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 401647-22-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:401647-22-1; Formule moléculaire:C6H10N2O; Point de fusion:-; Code SMILES:CC1=NOC(CNC)=C1; Densité:

: Numéro de catalogue:CM125217; Poids moléculaire:126.16; Point d'ébullition:; N° Mdl:MFCD08060065; Stockage:Store at 2-8°C.

: Isoxazoles; Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.